Navigation Links
Immtech Reports Fiscal Second Quarter 2008 Results
Date:11/8/2007

facts, are "forward-looking statements" that involve risks and uncertainties. Actual results could differ materially from these forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations" and "Risk Factors" in Immtech's annual report on Form 10-K for the year ended March 31, 2007 and in its other SEC filings and include: (i) Immtech's ability to develop commercially viable products; (ii) Immtech's ability to achieve profitability; (iii) Immtech's ability to retain key personnel; (iv) the ability of Immtech's scientists and collaborators to discover new compounds; (v) the availability of additional research grants; (vi) Immtech's ability to obtain regulatory approval of its drug candidate, including PCP; (vii) the success of Immtech's clinical trials; (viii) dependence upon and contractual relationship with partners; (ix) Immtech's ability to manufacture or to have a third party manufacture its drug candidate at a reasonable cost; (x) Immtech's ability to protect its intellectual property; (xi) competition and alternative technologies; (xii) Immtech's ability to obtain reimbursement from third party payers for any product it commercializes; and (xiii) potential exposure to significant product liability.

Immtech Pharmaceuticals, Inc.

Selected Financial Information (Unaudited)

(in thousands, except per share amounts)

Three Months Ended

September 30,

2007 2006

REVENUES $1,030 $491

OPERATING LOSS $(3,466) $(1,753)

NET LOSS T
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
3. Chinese SFDA Grants Immtech Fast Track Status
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
6. Immtech to Present at The Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. Spherix Reports Second Quarter Earnings
9. Tapestry Reports Second Quarter 2007 Results
10. Callisto Reports on Second-Quarter 2007 Milestones
11. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has ... China (Basel, Switzerland - November 26-27, 2015)" conference to ... detailed overview of the key areas of pharmaceutical regulatory affairs ... , Macau and ... All important aspects of gaining and maintaining a successful Marketing ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP ... bellwether trial will commence October 13, 2015. ... the 510K fast-track approval program, Zimmer NexGen knee implant ... only requires that companies provide evidence that the product ... in order to gain permissions. In ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: H. Lundbeck ... Introduction ... for Lundbeck in the prescription pharmaceutical sector. The ...
... 13, 2011 Reportlinker.com announces that a new ... Merck & Co., Inc.: PharmaVitae ... IntroductionThis analysis examines the historical and ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Reportlinker Adds H. Lundbeck A/S: PharmaVitae Profile 2Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:9/3/2015)... ... , ... A scar is an unavoidable result of incision or injury to the skin. Unsightly ... heal itself. The appearance of a scar is dependent on many factors – the size ... ”Many scars fade to near invisibility on their own over a period of months,” says ...
(Date:9/3/2015)... ... September 03, 2015 , ... The new ... Report of Provo, Utah. The Clinicians Report is a leading information source to ... located throughout the U.S. Whiter Image's In-Office whitening kits were favorably validated for ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will be hosting an upcoming ... James Earl Jones will introduce a segment that discusses why it is important for ... wellness can be fostered in any working environment. , Employers are out billions of ...
(Date:9/2/2015)... ... ... The Aspen Clinic (TAC), located in Basalt, Colorado, today announced ... wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, Executive Director of ... fitness - we are much more than a gym. Our fitness and wellness ...
(Date:9/2/2015)... ... September 02, 2015 , ... The CRISPR-Cas9 system introduces ... of the Cas9 nuclease with either a chimeric single guide RNA (sgRNA) or two ... any given guide RNA (sgRNA or crRNA) to create a break in the target ...
Breaking Medicine News(10 mins):Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4
... Financial Options Guide Now Available at Sunrise Communities and ... (NYSE: SRZ ) now offers a new ... ideas for affording senior care in today,s challenging economy. ... Financial Options , is available at Sunrise communities nationwide ...
... to be a first-ever procedure, surgeons at Johns Hopkins ... small incision in the back of the donor,s vagina. ... the donor,s niece, and both patients are doing fine," ... division at Johns Hopkins University School of Medicine who ...
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... call with simultaneous webcast on Tuesday, February 3, 2009 ... of Rigel,s senior management team will provide an update ... and Webcast Information To access the live call, please ...
... EPS Despite a Challenging Economic Environment BEDFORD, Mass., Feb. 2 ... HOLX ), a leading developer, manufacturer and supplier of premium ... the healthcare needs of women, today announced its results for ... quarter include: , ...
... common minimally invasive biopsy method used in the US, ... 14-gauge needle decreasing a physician,s chances of false-negative diagnoses, ... School of Medicine in Stanford, CA. , The ... using a 14-gauge or 11-gauge vacuum needle. Results showed ...
... February 02, 2009 The antiepileptic drug vigabatrin (VGB) has ... a special form of epilepsy in infants, called infantile spasm. ... it has been shown to cause a permanent narrowing of ... been exposed at school age or later. A new study ...
Cached Medicine News:Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2Health News:Hopkins transplant surgeons remove healthy kidney through donor's vagina 2Health News:Rigel to Host Conference Call on February 3, 2009 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 3Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 4Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 5Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 6Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 7Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 8Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 9Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 10Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 11Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 12Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 13Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 14Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 15Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 16Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 17Health News:Controversial medication may decrease spasms for infants with epilepsy 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: